e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 110

Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome

Alex P. Di Battista; John E. Buonora; Shawn G. Rhind; Michael G. Hutchison; Andrew Baker; Sandro Rizoli; Ramon Diaz‐Arrastia; Gregory P. Mueller · 2015 · Frontiers in Neurology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Blood biomarkers are valuable tools for elucidating complex cellular and molecular mechanisms underlying traumatic brain injury (TBI). Profiling distinct classes of biomarkers could aid in the identification and characterization of initial injury and secondary pathological processes. This study characterized the prognostic performance of a recently developed multi-marker panel of circulating biomarkers that reflect specific pathogenic mechanisms including neuroinflammation, oxidative damage, and neuroregeneration, in moderate-to-severe TBI patients. MATERIALS AND METHODS: Periphera

Abstract by Alex P. Di Battista; John E. Buonora; Shawn G. Rhind; Michael G. Hutchison; Andrew Baker; Sandro Rizoli; Ramon Diaz‐Arrastia; Gregory P. Mueller, Frontiers in Neurology (2015) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3389/fneur.2015.00110